课题基金 / 基金详情

Escape mechanisms of HIV-1 from HIV-1-specific CTLs

Escape mechanisms of HIV-1 from HIV-1-specific CTLs
HIV-1 从 HIV-1 特异性 CTL 中逃逸的机制
批准号:
18390141
负责人:
TAKIGUCHI Masafumi
金额:
$10.44万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

TAKIGUCHI Masafumi的其他基金

相似基金

相关文献

中文摘要
翻译
众所周知,人类白细胞抗原-B^*57/58、-B^*27和-B*51等位基因与艾滋病的缓慢进展有关,但这些等位基因所限制的细胞毒性T淋巴细胞(CTL)在HIV-1长期控制中的作用仍不清楚。我们研究了携带人类白细胞抗原B^*5101的长期非进展型(LTNP)和进展缓慢(慢进型)血友病患者中HIV-1特异性CTL。在LTNPs中同时检测到Pol283-8和Pol743-9特异的CTL,它们在体外都有很强的抑制HIV-1复制的能力,而在进展缓慢的人中只检测到Pol743-9特异的CTL。LTNPs具有HIV-1在这些表位上的野生型序列或突变,降低了特定CTL抑制HIV-1复制和病毒适合性的能力。相比之下,进展缓慢的人和进步的人携带的HIV-1带有逃逸突变,不会影响病毒的适合性。对一例血友病患者的纵向分析证实,Pol283-8逃逸突变的出现与高病毒载量之间存在关联。诱导具有较强抑制HIV-1复制能力的HIV-1特异性CTL,并进化为病毒适合性和T细胞识别能力降低的突变株,被发现对HIV-1的控制大约25年是必要的。
英文摘要
It is well known that HLA-B^*57/58, -B^*27, and -B*^51 alleles are associated with slow disease progression to AIDS, but the role of cytotoxic T lymphocytes(CTLs)restricted by these alleles in long-term control of HIV-1 still remains unknown. We investigated HIV-1-specific CTLs in long-term non-progressing(LTNP)and slow-progressing(slow progressors)hemophiliacs carrying HLA-B^*5101. Both Pol283-8-specific and Pol743-9-specific CTLs, which have a strong ability to suppress HIV-1 replication in vitro, were detected in LTNPs whereas only Pol743-9-specific CTLs were found in the slow progressors. The LTNPs had HIV-1 possessing wild-type sequence in these epitopes or a mutation reducing the ability of the specific CTLs to suppress HIV-1 replication and viral fitness. In contrast, the slow progressors and progressors had HIV-1 with escape mutations that did not influence viral fitness. Longitudinal analysis of a hemophiliac confirmed the association between the appearance of a Pol283-8 escape mutant and a high viral load. The induction of HIV-1-specific CTLs with a strong ability to suppress HIV-1 replication and the evolution to a mutant with reduced viral fitness and T cell recognition were found to be necessary for the control of HIV-1 for approximately 25 years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Different Ability of Escape Mutant-Specific Cytotoxic T Cells to Suppress Replication of Escape Mutant and Wild-type HIV-1 in New Hosts
逃逸突变体特异性细胞毒性 T 细胞抑制逃逸突变体和野生型 HIV-1 在新宿主中复制的不同能力
DOI: --
发表时间: 2008
期刊: Journal of Virology 82
影响因子: --
作者: [Nogi T, Yasui N, Mihara E, Matsunaga Y, Noda M, Yamashita N, Toyofuku T, Uchiyama S, Goshima Y, Kumanogoh A, Takagi J., Mamoru Fujiwara]
通讯作者: Mamoru Fujiwara
DOI: 10.1128/jvi.80.4.1949-1958.2006
发表时间: 2006-02-01
期刊: JOURNAL OF VIROLOGY
影响因子: 5.4
作者: [Kawada, M, Igarashi, H, Matano, T]
通讯作者: Matano, T
「研究成果報告書概要(和文)」より
摘自《研究结果报告摘要(日文)》
DOI: --
发表时间: 2005
期刊:
影响因子: --
作者: [Kawauchi, et. al., Nishimura et al., Dezawa et al., Yoshizawa et al., 星野 幹雄, 星野 幹雄]
通讯作者: 星野 幹雄
Long-term Control of HIV-1 by HIV-1-Specific CTLs and Appearance of Lower Fitness Virus in HLA-B^*51+ Long term non-progressors
HIV-1 特异性 CTL 对 HIV-1 的长期控制以及 HLA-B^*51 长期非进展者中低适应性病毒的出现
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [Yuka, Kawashima]
通讯作者: Kawashima
10
    A study of therapy and prevention in a Vietnamese cohort of HIV-1 infection
    • 批准号:
      15H02658
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $26.96万
    • 财政年份:
      2015
    • 负责人:
      TAKIGUCHI Masafumi
    • 依托单位:
    A study of HIV-1 escape mutants selected by cellular immunity
    • 批准号:
      20390134
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2008
    • 负责人:
      TAKIGUCHI Masafumi
    • 依托单位:
    Development of personal vaccine for virus
    • 批准号:
      10557034
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $7.49万
    • 财政年份:
      1998
    • 负责人:
      TAKIGUCHI Masafumi
    • 依托单位:
    Studies of T cell Recognition for Viral Antigen Epitopes
    • 批准号:
      10470088
    • 项目类别:
      Grant-in-Aid for Scientific Research (B).
    • 资助金额:
      $6.91万
    • 财政年份:
      1998
    • 负责人:
      TAKIGUCHI Masafumi
    • 依托单位:
    海外基金